Aristo Vanguard
The 7th Genome Editing Therapeutics Summit 2026 focuses on advancing genome editing therapies from scientific innovation to safe, scalable clinical applications. It covers in vivo and ex vivo delivery, regulatory compliance, and manufacturing challenges for drug development leaders.
Hanson Wade
Website:hansonwade.com
Looking for co-exhibitors or regional distributors?
Connect with verified business partners attending this exhibition.